HCM
INSM icon

Highbridge Capital Management’s Insmed INSM Stock Holding History

Highbridge Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-36,930
Closed -$489K – 1545
2016
Q4 		$489K Buy
36,930
+26,381
+250% +$360K 0.01% 780
2016
Q3 		$153K Sell
10,549
-40,823
-79% -$511K ﹤0.01% 1219
2016
Q2 		$507K Buy
+51,372
New +$599K 0.01% 842
2014
Q2 		– Sell
-26,083
Closed -$496K – 1170
2014
Q1 		$496K Buy
+26,083
New +$496K 0.01% 706

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Highbridge Capital Management's INSM Position: Q1 2017 in Review

Highbridge Capital Management sold out of Insmed (INSM) in Q1 2017, closing a stake of 36,930 shares — an estimated $489K sold.

Highbridge Capital Management first reported a position in INSM in Q1 2014 and held it in 4 quarters. The position peaked at $507K in Q2 2016. 100 funds tracked by Wall St. Rank hold INSM as of Q1 2017.

  • Highbridge Capital Management reported no remaining Insmed position as of Q1 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 36,930 Insmed shares in Q1 2017, an estimated $489K.
  • Highbridge Capital Management first reported a position in Insmed in Q1 2014 and held it in 4 quarters.
  • Highbridge Capital Management's Insmed position peaked at $507K in Q2 2016.
  • 100 funds tracked by Wall St. Rank held Insmed as of Q1 2017.

Based on Highbridge Capital Management's 13F filing for Q1 2017, filed 15 May 2017.